Adicet Bio
ACET
ACET
49 hedge funds and large institutions have $56.6M invested in Adicet Bio in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
8% less funds holding
Funds holding: 53 → 49 (-4)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
49
Holding in Top 10
1
Calls
$14K
Puts
$3K
Top Buyers
| 1 | +$6.93M | |
| 2 | +$6.91M | |
| 3 | +$5.27M | |
| 4 |
O
OrbiMed
New York
|
+$3.45M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.03M |
Top Sellers
| 1 | -$5.61M | |
| 2 | -$459K | |
| 3 | -$388K | |
| 4 |
WIA
Wealthedge Investment Advisors
New York
|
-$243K |
| 5 |
Jane Street
New York
|
-$151K |
